Daymark Wealth Partners LLC Increases Stake in CVS Health Corporation (NYSE:CVS)

Daymark Wealth Partners LLC grew its position in CVS Health Corporation (NYSE:CVS - Free Report) by 24.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,967 shares of the pharmacy operator's stock after acquiring an additional 6,430 shares during the quarter. Daymark Wealth Partners LLC's holdings in CVS Health were worth $2,233,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Strategic Investment Advisors MI grew its holdings in shares of CVS Health by 2.3% in the first quarter. Strategic Investment Advisors MI now owns 8,466 shares of the pharmacy operator's stock worth $574,000 after purchasing an additional 194 shares during the last quarter. Horizon Bancorp Inc. IN boosted its holdings in shares of CVS Health by 7.4% in the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after buying an additional 180 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of CVS Health by 25.0% in the 1st quarter. International Assets Investment Management LLC now owns 13,995 shares of the pharmacy operator's stock valued at $948,000 after purchasing an additional 2,798 shares during the last quarter. New Covenant Trust Company N.A. purchased a new position in shares of CVS Health in the 1st quarter valued at approximately $230,000. Finally, Petros Family Wealth LLC purchased a new position in shares of CVS Health in the 1st quarter valued at approximately $217,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on CVS. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Piper Sandler lifted their target price on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $74.75.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Price Performance

CVS Health stock opened at $66.44 on Thursday. The company has a fifty day simple moving average of $64.81 and a 200-day simple moving average of $60.62. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $84.05 billion, a price-to-earnings ratio of 15.86, a PEG ratio of 0.97 and a beta of 0.56. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The company's revenue was up 7.0% compared to the same quarter last year. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.